Your session is about to expire
← Back to Search
Endotoxin for Alcohol Consumption Behavior
Study Summary
This trial will study the effects of endotoxin on drinking behavior in humans.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2016 Phase 1 & 2 trial • 10 Patients • NCT00923910Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am not pregnant or nursing and use effective birth control or am surgically sterile/postmenopausal.I drink more than the specified weekly limit for my gender.We will not include individuals who are likely to have severe alcohol withdrawal symptoms during the study. This includes people who have experienced things like distorted perceptions, seizures, confusion, or seeing things that aren't there when they've stopped drinking in the past. We will also exclude those who score higher than 8 on a scale that measures alcohol withdrawal symptoms during their initial appointments.I cannot consume alcohol due to a medical condition.I have used drugs for mental health, like anxiety or depression meds, in the last 30 days.You have been diagnosed with a drinking problem in the past 6 months according to the DSM-5 guidelines.I am between 21 and 65 years old.I do not have any major health issues like heart problems, kidney or liver disease, seizures, or HIV.I have not had severe mental health issues like schizophrenia, bipolar disorder, major depression, or anxiety in the past 6 months.
- Group 1: Endotoxin
- Group 2: Placebo
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has Endotoxin completed the necessary steps for FDA approval?
"There is early data supporting the safety of this medication, but nothing yet for efficacy. Consequently, we've given it a score of 2."
Does this research project allow people who are octogenarians to participate?
"According to the study's eligibility requirements, participants must be between 21 and 65 years old. Out of the 300 active trials, this is one of 34 that accept patients below 18 or above 65."
Are researchers actively looking for more participants for this trial?
"The online database clinicaltrials.gov indicates that this study is still looking for participants. This information was originally posted on January 27th, 2022 and last updated April 21st of the same year."
To whom is this trial open?
"To qualify for this study, individuals must suffer from alcoholism and be between 21-65 years old. Only 32 patients will be accepted in total."
How many people are being treated with this new medication?
"Yes, the information available on clinicaltrials.gov suggests that this research is ongoing and presently looking for more participants. The study was first made public on 1/27/2022 with the most recent update being on 4/21/2022. At the moment, 32 patients are needed at a single location."
Share this study with friends
Copy Link
Messenger